📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Affiris

1.1 - Company Overview

Affiris Logo

Affiris

Headquarter: Austria
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of tailor-made peptide vaccines and specific active immunotherapies for chronic diseases, including Alzheimer’s, Parkinson’s, atherosclerosis/hypercholesterolemia and hypertension. Portfolio includes AFFITOPE PD01/PD03 targeting alpha-synuclein, AFFITOPE AT04/AT06 targeting PCSK9 to lower LDL, mAB C6-17 for mutant huntingtin, and the SAIT modality.

Products and services

  • Specific Active ImmunoTherapy (SAIT): A treatment modality that harnesses immunity to target proteins in chronic diseases, inducing long-lasting responses enabling less frequent dosing
  • AFFITOPE PD01: A peptide-based immunotherapy for early-stage Parkinson’s disease that induces an immune response against alpha-synuclein to reduce the protein’s pathological effects
  • AFFITOPE AT06: A peptide vaccine targeting PCSK9 to lower LDL cholesterol, aiming to deliver a long-lasting immune response against hypercholesterolemia

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Affiris

Trillium Therapeutics Logo

Trillium Therapeutics

HQ: Canada Website
  • Description: Provider of biopharmaceutical research and development focused on immune system regulation and the discovery and development of protein therapeutics—including monoclonal antibodies, secreted proteins, and peptides—for cancer and autoimmune indications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Trillium Therapeutics company profile →
Maverick Therapeutics Logo

Maverick Therapeutics

HQ: United States Website
  • Description: Provider of T cell immunotherapies for solid tumor cancers, developing breakthrough treatments with improved safety and efficacy via COBRA, the most advanced bispecific T cell engaging platform in its class designed to safely target solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Maverick Therapeutics company profile →
Arsanis Logo

Arsanis

HQ: Austria Website
  • Description: Provider of biopharmaceutical infectious disease treatments based on bacterial protein and carbohydrate antigens.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arsanis company profile →
NextCure Logo

NextCure

HQ: United States Website
  • Description: Provider of biopharmaceutical discovery and development focused on next-generation immuno-oncology-based drugs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NextCure company profile →
Active Biotech Logo

Active Biotech

HQ: Sweden Website
  • Description: Provider of biotechnology research and development of pharmaceuticals and vaccines, based on knowledge of autoimmune/inflammatory diseases and cancer, developing products to treat conditions including multiple sclerosis and lung and renal diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Active Biotech company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Affiris

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Affiris

2.2 - Growth funds investing in similar companies to Affiris

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Affiris

4.2 - Public trading comparable groups for Affiris

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Affiris

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Affiris

What does Affiris do?

Affiris is a provider of tailor-made peptide vaccines and specific active immunotherapies for chronic diseases, including Alzheimer’s, Parkinson’s, atherosclerosis/hypercholesterolemia and hypertension. Portfolio includes AFFITOPE PD01/PD03 targeting alpha-synuclein, AFFITOPE AT04/AT06 targeting PCSK9 to lower LDL, mAB C6-17 for mutant huntingtin, and the SAIT modality.

Who are Affiris's competitors?

Affiris's competitors and similar companies include Trillium Therapeutics, Maverick Therapeutics, Arsanis, NextCure, and Active Biotech.

Where is Affiris headquartered?

Affiris is headquartered in Austria.

How many employees does Affiris have?

Affiris has 1,000 employees 🔒.

When was Affiris founded?

Affiris was founded in 2010 🔒.

What sector and industry vertical is Affiris in?

Affiris is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Affiris

Who are the top strategic acquirers in Affiris's sector and industry

Top strategic M&A buyers and acquirers in Affiris's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Affiris?

Top strategic M&A buyers groups and sectors for Affiris include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Affiris's sector and industry vertical

Which are the top PE firms investing in Affiris's sector and industry vertical?

Top PE firms investing in Affiris's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Affiris's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Affiris's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Affiris's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Affiris include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Affiris's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Affiris?

The key public trading comparables and valuation benchmarks for Affiris include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Affiris for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Affiris with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Affiris's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Affiris with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Affiris's' sector and industry vertical?

Access recent funding rounds and capital raises in Affiris's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Affiris